Increased  	Increased  	 JJ	B-NP
IL-17A  	IL-17A  	 NN	I-NP
in  	in  	 IN	O
atrial  	atrial  	 JJ	B-NP
fibrillation  	fibrillation  	 JJ	I-NP
correlates  	correlates  	 NN	O
with  	with  	 IN	O
neutrophil  	neutrophil  	 VBG	O
to  	to  	 TO	O
lymphocyte  	lymphocyte  	 VB	O
ratio  	ratio  	 NN	B-NP
Atrial  	Atrial  	 NNP	I-NP
Fibrillation  	Fibrillation  	 NNP	I-NP
( 	( 	 -LRB-	O
AF 	AF 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
the  	the  	 DT	O
most  	most  	 RBS	O
common  	common  	 JJ	O
cardiac  	cardiac  	 JJ	B-NP
arrhythmia  	arrhythmia  	 NN	I-NP
and  	and  	 CC	O
an  	an  	 DT	O
independent  	independent  	 JJ	O
risk  	risk  	 NN	B-NP
factor  	factor  	 NN	I-NP
for  	for  	 IN	O
stroke  	stroke  	 NN	O
among  	among  	 IN	O
the  	the  	 DT	O
elderly 	elderly 	 JJ	O
.  	.  	 .	O
A  	A  	 DT	O
role  	role  	 NN	O
for  	for  	 IN	O
inflammation  	inflammation  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
atrial  	atrial  	 JJ	B-NP
remodeling  	remodeling  	 NN	I-NP
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
development  	development  	 NN	O
and  	and  	 CC	O
recurrence  	recurrence  	 NN	O
of  	of  	 IN	O
AF  	AF  	 NNP	B-NP
is  	is  	 VBZ	O
known 	known 	 VBN	O
.  	.  	 .	O
To  	To  	 TO	O
compare  	compare  	 VB	O
IL-17A  	IL-17A  	 CD	B-NP
between  	between  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
different  	different  	 JJ	O
types  	types  	 NNS	O
of  	of  	 IN	O
AF  	AF  	 NNP	B-NP
and  	and  	 CC	O
healthy  	healthy  	 JJ	O
individuals 	individuals 	 NNS	O
.  	.  	 .	O
IL-17A  	IL-17A  	 NNP	B-NP
was  	was  	 VBD	O
measured  	measured  	 VBN	O
in  	in  	 IN	O
sera  	sera  	 NN	B-NP
of  	of  	 IN	O
112  	112  	 CD	O
patients  	patients  	 NNS	O
and  	and  	 CC	O
107  	107  	 CD	O
healthy  	healthy  	 JJ	O
age 	age 	 NN	B-NP
/ 	/ 	 NNP	I-NP
sex-matched  	sex-matched  	 NNP	I-NP
controls  	controls  	 VBZ	O
using  	using  	 VBG	O
ELISA  	ELISA  	 NNP	B-NP
assay 	assay 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
sera  	sera  	 NN	B-NP
of  	of  	 IN	O
26  	26  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
elevated  	elevated  	 CD	B-NP
IL-17A  	IL-17A  	 CD	I-NP
( 	( 	 -LRB-	O
> 	> 	 CD	O
1  	1  	 CD	O
Pg 	Pg 	 CD	B-NP
/ 	/ 	 CD	I-NP
ml 	ml 	 CD	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
CCL5  	CCL5  	 NNP	B-NP
and  	and  	 CC	O
CCL18  	CCL18  	 CD	B-NP
levels  	levels  	 NNS	I-NP
were  	were  	 VBD	O
also  	also  	 RB	O
measured 	measured 	 VBN	O
.  	.  	 .	O
IL-17A  	IL-17A  	 NNP	B-NP
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
increased  	increased  	 VBN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
AF  	AF  	 NNP	B-NP
compared  	compared  	 VBN	O
to  	to  	 TO	O
controls  	controls  	 NNS	O
( 	( 	 -LRB-	O
1.28  	1.28  	 CD	O
±  	±  	 CD	O
3.5  	3.5  	 CD	O
vs.  	vs.  	 FW	O
0.19  	0.19  	 FW	O
±  	±  	 FW	O
0.64  	0.64  	 FW	O
Pg 	Pg 	 FW	B-NP
/ 	/ 	 FW	I-NP
ml 	ml 	 FW	I-NP
,  	,  	 ,	O
p=0.001 	p=0.001 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
There  	There  	 EX	O
was  	was  	 VBD	O
no  	no  	 DT	O
significant  	significant  	 JJ	O
difference  	difference  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
level  	level  	 NN	O
of  	of  	 IN	O
IL-17A  	IL-17A  	 CD	B-NP
between  	between  	 IN	O
different  	different  	 JJ	O
types  	types  	 NNS	O
of  	of  	 IN	O
AF 	AF 	 NNP	B-NP
.  	.  	 .	O
IL-17A  	IL-17A  	 NNP	B-NP
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
a  	a  	 DT	O
history  	history  	 NN	O
of  	of  	 IN	O
coronary  	coronary  	 JJ	B-NP
artery  	artery  	 NN	I-NP
bypass  	bypass  	 NNS	I-NP
graft  	graft  	 VBP	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
other  	other  	 JJ	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
p=0.01 	p=0.01 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
A  	A  	 DT	O
significant  	significant  	 JJ	O
positive  	positive  	 JJ	B-NP
correlation  	correlation  	 NN	I-NP
between  	between  	 IN	O
IL-17A  	IL-17A  	 NNP	B-NP
and  	and  	 CC	O
CCL18  	CCL18  	 CD	B-NP
concentration  	concentration  	 NN	I-NP
was  	was  	 VBD	O
found  	found  	 VBN	O
( 	( 	 -LRB-	O
p=0.001 	p=0.001 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
An  	An  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
Neutrophil 	Neutrophil 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Lymphocyte  	Lymphocyte  	 NNP	I-NP
ratio  	ratio  	 NN	I-NP
( 	( 	 -LRB-	O
NLR 	NLR 	 NNP	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
elevated  	elevated  	 JJ	O
serum  	serum  	 NNS	B-NP
IL-17A  	IL-17A  	 VBP	I-NP
compared  	compared  	 VBN	O
to  	to  	 TO	O
other  	other  	 JJ	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
p=0.006 	p=0.006 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Male  	Male  	 JJ	O
patients  	patients  	 NNS	O
showed  	showed  	 VBD	O
higher  	higher  	 JJR	O
increase  	increase  	 NN	O
in  	in  	 IN	O
NLR  	NLR  	 NNP	B-NP
( 	( 	 -LRB-	O
p=0.007 	p=0.007 	 NNP	O
)  	)  	 -RRB-	O
which  	which  	 WDT	O
was  	was  	 VBD	O
accompanied  	accompanied  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
decrease  	decrease  	 NN	O
in  	in  	 IN	O
CCL5  	CCL5  	 NNP	B-NP
( 	( 	 -LRB-	O
p=0.000 	p=0.000 	 NNP	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
a  	a  	 DT	O
marginal  	marginal  	 JJ	B-NP
increase  	increase  	 NN	I-NP
in  	in  	 IN	O
CCL18  	CCL18  	 NNP	B-NP
( 	( 	 -LRB-	O
p=0.085 	p=0.085 	 NNP	O
)  	)  	 -RRB-	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
females 	females 	 NNS	O
.  	.  	 .	O
There  	There  	 EX	O
was  	was  	 VBD	O
an  	an  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
CCL5  	CCL5  	 CD	B-NP
levels  	levels  	 NNS	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
receiving  	receiving  	 VBG	B-NP
Acetylsalicylic  	Acetylsalicylic  	 NNP	I-NP
Acid  	Acid  	 NNP	I-NP
( 	( 	 -LRB-	O
ASA 	ASA 	 NNP	B-NP
)  	)  	 -RRB-	O
therapy  	therapy  	 NN	O
( 	( 	 -LRB-	O
p=0.046 	p=0.046 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
IL-17A  	IL-17A  	 CD	B-NP
levels  	levels  	 NNS	I-NP
is  	is  	 VBZ	O
related  	related  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
AF  	AF  	 NNP	B-NP
pathology  	pathology  	 VBD	I-NP
mediated  	mediated  	 VBN	O
by  	by  	 IN	O
neutrophils  	neutrophils  	 NN	B-NP
and  	and  	 CC	O
monocytes 	monocytes 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
current  	current  	 JJ	O
study  	study  	 NN	O
signifies  	signifies  	 VBD	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
immune  	immune  	 JJ	O
cells  	cells  	 NNS	O
and  	and  	 CC	O
cytokines  	cytokines  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
pathology  	pathology  	 NN	B-NP
of  	of  	 IN	I-NP
AF 	AF 	 NNP	I-NP
.  	.  	 .	O
